江蘇雷利(300660.SZ)一季度淨利潤預增50%至90%
格隆匯 4 月 11日丨江蘇雷利(300660.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤7348.18萬元-9307.70萬元,同比增長50%至90%。業績變動原因如下:
(1)報吿期內,隨着公司產業鏈佈局的不斷完善,海外生產基地的穩步運行,公司在客户羣體中競爭優勢愈發明顯,營業收入實現穩步增長。
(2)研發創新、工藝改善的成果逐步轉化,家電、汽車、醫療及運動健康板塊業務持續發力,使得公司綜合盈力能力顯著提升。
(3)預計公司2021年第一季度非經常性損益對淨利潤的影響為500萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.